Fiocchi C - Search Results

1

Review article: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis - a unique therapeutic target in inflammatory bowel disease.

Wang J, Goren I, Yang B, Lin S, Li J, Elias M, Fiocchi C, Rieder F. Wang J, et al. Aliment Pharmacol Ther. 2022 Feb;55(3):277-291. doi: 10.1111/apt.16741. Epub 2021 Dec 21. Aliment Pharmacol Ther. 2022. PMID: 34932238 Free PMC article. Review.

2

Soluble interleukin 2 and CD8 and CD4 receptors in inflammatory bowel disease.

Matsuura T, West GA, Klein JS, Ferraris L, Fiocchi C. Matsuura T, et al. Gastroenterology. 1992 Jun;102(6):2006-14. doi: 10.1016/0016-5085(92)90326-t. Gastroenterology. 1992. PMID: 1587419

3

Immune activation genes in inflammatory bowel disease.

Matsuura T, West GA, Youngman KR, Klein JS, Fiocchi C. Matsuura T, et al. Gastroenterology. 1993 Feb;104(2):448-58. doi: 10.1016/0016-5085(93)90413-7. Gastroenterology. 1993. PMID: 8425687

4

Pitfalls in cytokine analysis in inflammatory bowel disease.

Fiocchi C, Fukushima K, Strong SA, Ina K. Fiocchi C, et al. Aliment Pharmacol Ther. 1996;10 Suppl 2:63-9; discussion 70-1. doi: 10.1046/j.1365-2036.1996.22164022.x. Aliment Pharmacol Ther. 1996. PMID: 8899103 Review.

5

Inflammatory bowel disease.

Gurudu S, Fiocchi C, Katz JA. Gurudu S, et al. Best Pract Res Clin Gastroenterol. 2002 Feb;16(1):77-90. doi: 10.1053/bega.2001.0267. Best Pract Res Clin Gastroenterol. 2002. PMID: 11977930 Review.

6

Gastroesophageal reflux disease-associated esophagitis induces endogenous cytokine production leading to motor abnormalities.

Rieder F, Cheng L, Harnett KM, Chak A, Cooper GS, Isenberg G, Ray M, Katz JA, Catanzaro A, O'Shea R, Post AB, Wong R, Sivak MV, McCormick T, Phillips M, West GA, Willis JE, Biancani P, Fiocchi C. Rieder F, et al. Gastroenterology. 2007 Jan;132(1):154-65. doi: 10.1053/j.gastro.2006.10.009. Epub 2006 Oct 12. Gastroenterology. 2007. PMID: 17241868

7

Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical science.

Rieder F, Fiocchi C. Rieder F, et al. Curr Opin Gastroenterol. 2008 Jul;24(4):462-8. doi: 10.1097/MOG.0b013e3282ff8b36. Curr Opin Gastroenterol. 2008. PMID: 18622160 Review.

8

Intestinal fibrosis in IBD--a dynamic, multifactorial process.

Rieder F, Fiocchi C. Rieder F, et al. Nat Rev Gastroenterol Hepatol. 2009 Apr;6(4):228-35. doi: 10.1038/nrgastro.2009.31. Nat Rev Gastroenterol Hepatol. 2009. PMID: 19347014 Review.

9

Susceptibility genes and overall pathogenesis of inflammatory bowel disease: where do we stand?

Fiocchi C. Fiocchi C. Dig Dis. 2009;27(3):226-35. doi: 10.1159/000228554. Epub 2009 Sep 24. Dig Dis. 2009. PMID: 19786745 Review.

10

Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy.

Schirbel A, Fiocchi C. Schirbel A, et al. J Dig Dis. 2010 Oct;11(5):266-76. doi: 10.1111/j.1751-2980.2010.00449.x. J Dig Dis. 2010. PMID: 20883422 Review.

11

First international summit on fibrosis in intestinal inflammation: mechanisms and biological therapies.

Rieder F, Fiocchi C. Rieder F, et al. Fibrogenesis Tissue Repair. 2010 Nov 11;3:22. doi: 10.1186/1755-1536-3-22. Fibrogenesis Tissue Repair. 2010. PMID: 21070635 Free PMC article.

12

Pathogenesis of postoperative recurrence in Crohn's disease.

Ahmed T, Rieder F, Fiocchi C, Achkar JP. Ahmed T, et al. Gut. 2011 Apr;60(4):553-62. doi: 10.1136/gut.2010.221705. Epub 2010 Nov 29. Gut. 2011. PMID: 21115545 Review.

13

Intestinal fibrosis in inflammatory bowel disease - Current knowledge and future perspectives.

Rieder F, Fiocchi C. Rieder F, et al. J Crohns Colitis. 2008 Dec;2(4):279-90. doi: 10.1016/j.crohns.2008.05.009. Epub 2008 Jul 3. J Crohns Colitis. 2008. PMID: 21172225

14

Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis.

Rieder F, Kessler SP, West GA, Bhilocha S, de la Motte C, Sadler TM, Gopalan B, Stylianou E, Fiocchi C. Rieder F, et al. Am J Pathol. 2011 Nov;179(5):2660-73. doi: 10.1016/j.ajpath.2011.07.042. Epub 2011 Sep 21. Am J Pathol. 2011. PMID: 21945322 Free PMC article.

15

Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease.

Rieder F, Kessler S, Sans M, Fiocchi C. Rieder F, et al. Am J Physiol Gastrointest Liver Physiol. 2012 Oct;303(7):G786-801. doi: 10.1152/ajpgi.00059.2012. Epub 2012 Aug 9. Am J Physiol Gastrointest Liver Physiol. 2012. PMID: 22878121 Free PMC article. Review.

16

Pro-angiogenic activity of TLRs and NLRs: a novel link between gut microbiota and intestinal angiogenesis.

Schirbel A, Kessler S, Rieder F, West G, Rebert N, Asosingh K, McDonald C, Fiocchi C. Schirbel A, et al. Gastroenterology. 2013 Mar;144(3):613-623.e9. doi: 10.1053/j.gastro.2012.11.005. Epub 2012 Nov 10. Gastroenterology. 2013. PMID: 23149220 Free PMC article.

17

Genes and 'in-vironment': how will our concepts on the pathophysiology of inflammatory bowel disease develop in the future?

Fiocchi C. Fiocchi C. Dig Dis. 2012;30 Suppl 3:2-11. doi: 10.1159/000342585. Epub 2013 Jan 3. Dig Dis. 2012. PMID: 23295686 Review.

18

Mechanisms of tissue remodeling in inflammatory bowel disease.

Rieder F, Fiocchi C. Rieder F, et al. Dig Dis. 2013;31(2):186-93. doi: 10.1159/000353364. Epub 2013 Sep 6. Dig Dis. 2013. PMID: 24030223 Review.

19

Advances in therapeutic interventions targeting the vascular and lymphatic endothelium in inflammatory bowel disease.

D'Alessio S, Tacconi C, Fiocchi C, Danese S. D'Alessio S, et al. Curr Opin Gastroenterol. 2013 Nov;29(6):608-13. doi: 10.1097/MOG.0b013e328365d37c. Curr Opin Gastroenterol. 2013. PMID: 24100721 Review.

20

T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis.

Rieder F, Nonevski I, Ma J, Ouyang Z, West G, Protheroe C, DePetris G, Schirbel A, Lapinski J, Goldblum J, Bonfield T, Lopez R, Harnett K, Lee J, Hirano I, Falk G, Biancani P, Fiocchi C. Rieder F, et al. Gastroenterology. 2014 May;146(5):1266-77.e1-9. doi: 10.1053/j.gastro.2014.01.051. Epub 2014 Jan 28. Gastroenterology. 2014. PMID: 24486052 Free PMC article.

21

IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis.

Fuss IJ, Joshi B, Yang Z, Degheidy H, Fichtner-Feigl S, de Souza H, Rieder F, Scaldaferri F, Schirbel A, Scarpa M, West G, Yi C, Xu L, Leland P, Yao M, Mannon P, Puri RK, Fiocchi C, Strober W. Fuss IJ, et al. Gut. 2014 Nov;63(11):1728-36. doi: 10.1136/gutjnl-2013-305671. Epub 2014 Feb 10. Gut. 2014. PMID: 24515806 Free PMC article.

22

Fibrosis in ulcerative colitis: mechanisms, features, and consequences of a neglected problem.

Gordon IO, Agrawal N, Goldblum JR, Fiocchi C, Rieder F. Gordon IO, et al. Inflamm Bowel Dis. 2014 Nov;20(11):2198-206. doi: 10.1097/MIB.0000000000000080. Inflamm Bowel Dis. 2014. PMID: 24892966

23

Review article: breath analysis in inflammatory bowel diseases.

Kurada S, Alkhouri N, Fiocchi C, Dweik R, Rieder F. Kurada S, et al. Aliment Pharmacol Ther. 2015 Feb;41(4):329-41. doi: 10.1111/apt.13050. Epub 2014 Dec 19. Aliment Pharmacol Ther. 2015. PMID: 25523187 Review.

24

Letter: volatile metabolomics of exhaled breath or faecal gas? - authors' reply.

Kurada S, Alkhouri N, Fiocchi C, Dweik R, Rieder F. Kurada S, et al. Aliment Pharmacol Ther. 2015 Apr;41(7):704. doi: 10.1111/apt.13127. Aliment Pharmacol Ther. 2015. PMID: 25736153 No abstract available.

25

Inflammatory bowel disease pathogenesis: where are we?

Fiocchi C. Fiocchi C. J Gastroenterol Hepatol. 2015 Mar;30 Suppl 1:12-8. doi: 10.1111/jgh.12751. J Gastroenterol Hepatol. 2015. PMID: 25827798 Review.

26

Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases.

Rieder F, Fiocchi C, Rogler G. Rieder F, et al. Gastroenterology. 2017 Feb;152(2):340-350.e6. doi: 10.1053/j.gastro.2016.09.047. Epub 2016 Oct 5. Gastroenterology. 2017. PMID: 27720839 Free PMC article. Review.

27

A Distinct Colon-Derived Breath Metabolome is Associated with Inflammatory Bowel Disease, but not its Complications.

Rieder F, Kurada S, Grove D, Cikach F, Lopez R, Patel N, Singh A, Alkhouri N, Shen B, Brzezinski A, Baker M, Fiocchi C, Dweik RA. Rieder F, et al. Clin Transl Gastroenterol. 2016 Nov 10;7(11):e201. doi: 10.1038/ctg.2016.57. Clin Transl Gastroenterol. 2016. PMID: 27831543 Free PMC article.

28

Fibrosis in ulcerative colitis is directly linked to severity and chronicity of mucosal inflammation.

Gordon IO, Agrawal N, Willis E, Goldblum JR, Lopez R, Allende D, Liu X, Patil DY, Yerian L, El-Khider F, Fiocchi C, Rieder F. Gordon IO, et al. Aliment Pharmacol Ther. 2018 Apr;47(7):922-939. doi: 10.1111/apt.14526. Epub 2018 Feb 6. Aliment Pharmacol Ther. 2018. PMID: 29411405 Free PMC article.

29

Network Medicine: A Mandatory Next Step for Inflammatory Bowel Disease.

de Souza HSP, Fiocchi C. de Souza HSP, et al. Inflamm Bowel Dis. 2018 Mar 19;24(4):671-679. doi: 10.1093/ibd/izx111. Inflamm Bowel Dis. 2018. PMID: 29562278 Review.

30

Mutual Regulation of TLR/NLR and CEACAM1 in the Intestinal Microvasculature: Implications for IBD Pathogenesis and Therapy.

Schirbel A, Rebert N, Sadler T, West G, Rieder F, Wagener C, Horst A, Sturm A, de la Motte C, Fiocchi C. Schirbel A, et al. Inflamm Bowel Dis. 2019 Jan 10;25(2):294-305. doi: 10.1093/ibd/izy316. Inflamm Bowel Dis. 2019. PMID: 30295747 Free PMC article.

31

Acupuncture in Inflammatory Bowel Disease.

Song G, Fiocchi C, Achkar JP. Song G, et al. Inflamm Bowel Dis. 2019 Jun 18;25(7):1129-1139. doi: 10.1093/ibd/izy371. Inflamm Bowel Dis. 2019. PMID: 30535303 Review.

32

Selective deletion of MyD88 signaling in α-SMA positive cells ameliorates experimental intestinal fibrosis via post-transcriptional regulation.

Zhao S, Dejanovic D, Yao P, Bhilocha S, Sadler T, Schirbel A, West G, Doyon G, Lopez R, Mao R, Kurada S, El Ouali S, Grassl G, Fox PL, Cruise M, Worthley DL, de la Motte C, Fiocchi C, Rieder F. Zhao S, et al. Mucosal Immunol. 2020 Jul;13(4):665-678. doi: 10.1038/s41385-020-0259-9. Epub 2020 Feb 4. Mucosal Immunol. 2020. PMID: 32020030 Free PMC article.

33

IBD Systems Biology Is Here to Stay.

Fiocchi C, Iliopoulos D. Fiocchi C, et al. Inflamm Bowel Dis. 2021 May 17;27(6):760-770. doi: 10.1093/ibd/izaa343. Inflamm Bowel Dis. 2021. PMID: 33438720

34

IL-36 in chronic inflammation and fibrosis - bridging the gap?

Elias M, Zhao S, Le HT, Wang J, Neurath MF, Neufert C, Fiocchi C, Rieder F. Elias M, et al. J Clin Invest. 2021 Jan 19;131(2):e144336. doi: 10.1172/JCI144336. J Clin Invest. 2021. PMID: 33463541 Free PMC article. Review.

35

Activated intestinal muscle cells promote preadipocyte migration: a novel mechanism for creeping fat formation in Crohn's disease.

Mao R, Doyon G, Gordon IO, Li J, Lin S, Wang J, Le THN, Elias M, Kurada S, Southern B, Olman M, Chen M, Zhao S, Dejanovic D, Chandra J, Mukherjee PK, West G, Van Wagoner DR, Fiocchi C, Rieder F. Mao R, et al. Gut. 2022 Jan;71(1):55-67. doi: 10.1136/gutjnl-2020-323719. Epub 2021 Jan 19. Gut. 2022. PMID: 33468536 Free PMC article.

36

Novel mechanisms and clinical trial endpoints in intestinal fibrosis.

Wang J, Lin S, Brown JM, van Wagoner D, Fiocchi C, Rieder F. Wang J, et al. Immunol Rev. 2021 Jul;302(1):211-227. doi: 10.1111/imr.12974. Epub 2021 May 16. Immunol Rev. 2021. PMID: 33993489 Free PMC article. Review.

37

Inflammatory Bowel Disease Therapy: Beyond the Immunome.

Fiocchi C, Iliopoulos D. Fiocchi C, et al. Front Immunol. 2022 May 9;13:864762. doi: 10.3389/fimmu.2022.864762. eCollection 2022. Front Immunol. 2022. PMID: 35615360 Free PMC article. No abstract available.

38

Human intestinal myofibroblasts deposited collagen VI enhances adhesiveness for T cells - A novel mechanism for maintenance of intestinal inflammation.

Lin SN, Musso A, Wang J, Mukherjee PK, West GA, Mao R, Lyu R, Li J, Zhao S, Elias M, Haberman Y, Denson LA, Kugathasan S, Chen MH, Czarnecki D, Dejanovic D, Le HT, Chandra J, Lipman J, Steele SR, Nguyen QT, Fiocchi C, Rieder F. Lin SN, et al. Matrix Biol. 2022 Nov;113:1-21. doi: 10.1016/j.matbio.2022.09.001. Epub 2022 Sep 13. Matrix Biol. 2022. PMID: 36108990 Free PMC article.

39

Fibrosis in IBD: from pathogenesis to therapeutic targets.

Rieder F, Mukherjee PK, Massey WJ, Wang Y, Fiocchi C. Rieder F, et al. Gut. 2024 Apr 5;73(5):854-866. doi: 10.1136/gutjnl-2023-329963. Gut. 2024. PMID: 38233198 Free PMC article. Review.

40

Milk fat globule-epidermal growth factor 8 (MFGE8) prevents intestinal fibrosis.

Lin S, Wang J, Mukherjee PK, Mao R, West G, Czarnecki D, Zhao S, Nguyen QT, Elias M, Massey WJ, Liu W, Wang Y, Prasad A, Banerjee S, Goren I, Chandra J, Le HT, Dejanovic D, Li J, Chen M, Holubar S, Olman M, Southern B, Hu S, Gordon IO, Atabai K, Fiocchi C, Rieder F. Lin S, et al. Gut. 2024 Jun 6;73(7):1110-1123. doi: 10.1136/gutjnl-2022-328608. Gut. 2024. PMID: 38378253 Free PMC article.

41

Cellular and molecular mechanisms in the pathogenesis of pouchitis: more than just the microbiota.

Braga-Neto MB, Qazi T, Fulmer C, Holubar SD, Fiocchi C, Ivanov AI, Rieder F. Braga-Neto MB, et al. Among authors: fiocchi c. Gut. 2025 Oct 8;74(11):1905-1915. doi: 10.1136/gutjnl-2024-334445. Gut. 2025. PMID: 40240062 Free PMC article. Review.

42

Colonic vasoactive intestinal peptide nerves in inflammatory bowel disease.

Kubota Y, Petras RE, Ottaway CA, Tubbs RR, Farmer RG, Fiocchi C. Kubota Y, et al. Gastroenterology. 1992 Apr;102(4 Pt 1):1242-51. Gastroenterology. 1992. PMID: 1551531

43

Immune events associated with inflammatory bowel disease.

Fiocchi C. Fiocchi C. Scand J Gastroenterol Suppl. 1990;172:4-12. doi: 10.3109/00365529009091902. Scand J Gastroenterol Suppl. 1990. PMID: 2191424 Review.

44

Lymphokines and the intestinal immune response. Role in inflammatory bowel disease.

Fiocchi C. Fiocchi C. Immunol Invest. 1989 Jan-May;18(1-4):91-102. doi: 10.3109/08820138909112230. Immunol Invest. 1989. PMID: 2499538 Review.

45

High prevalence of antibodies to intestinal epithelial antigens in patients with inflammatory bowel disease and their relatives.

Fiocchi C, Roche JK, Michener WM. Fiocchi C, et al. Ann Intern Med. 1989 May 15;110(10):786-94. doi: 10.7326/0003-4819-110-10-786. Ann Intern Med. 1989. PMID: 2712462

46

Interferon gamma production by human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease.

Lieberman BY, Fiocchi C, Youngman KR, Sapatnekar WK, Proffitt MR. Lieberman BY, et al. Dig Dis Sci. 1988 Oct;33(10):1297-304. doi: 10.1007/BF01536683. Dig Dis Sci. 1988. PMID: 3139380

47

Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease.

Binion DG, West GA, Ina K, Ziats NP, Emancipator SN, Fiocchi C. Binion DG, et al. Gastroenterology. 1997 Jun;112(6):1895-907. doi: 10.1053/gast.1997.v112.pm9178682. Gastroenterology. 1997. PMID: 9178682

48

The immune system in inflammatory bowel disease.

Fiocchi C. Fiocchi C. Acta Gastroenterol Belg. 1997 Apr-Jun;60(2):156-62. Acta Gastroenterol Belg. 1997. PMID: 9260327 Review.

49

Inflammatory bowel disease: etiology and pathogenesis.

Fiocchi C. Fiocchi C. Gastroenterology. 1998 Jul;115(1):182-205. doi: 10.1016/s0016-5085(98)70381-6. Gastroenterology. 1998. PMID: 9649475 Review. No abstract available.

50

Etiopathogenesis of inflammatory bowel disease: the importance of the pediatric perspective.

Oliva-Hemker M, Fiocchi C. Oliva-Hemker M, et al. Inflamm Bowel Dis. 2002 Mar;8(2):112-28. doi: 10.1097/00054725-200203000-00008. Inflamm Bowel Dis. 2002. PMID: 11854610 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

254 results

Search Page

Filters